Medtronic Studies Cryoballoon As First-Line Atrial Fibrillation Option
This article was originally published in The Gray Sheet
Executive Summary
The firm will recruit over 200 patients across 12 European sites to evaluate if its Arctic Front Advance ablation therapy can benefit as a first-line treatment for atrial fibrillation rather than drugs.